Essa Pharma Inc (EPIX)

Oppenheimer Reiterates "Outperform" Rating for ESSA Pharma (NASDAQ:EPIX) - MarketBeat

MarketBeat

(EPIX) Trading Signals - Stock Traders Daily

Stock Traders Daily

ESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Growth in Short Interest - MarketBeat

MarketBeat

ESSA Pharma: Fiscal Q2 Earnings Snapshot - Darien Times

Darien Times

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31 ... - br.ADVFN.com

br.ADVFN.com

ESSA Pharma: Fiscal Q2 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Boyd Gaming Co. (NYSE:BYD) Short Interest Up 20.4% in April - Defense World

Defense World

Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech - Scrip

Scrip

ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below Fifty Day Moving Average of $7.91 - MarketBeat

MarketBeat

ESSA Pharma (NASDAQ:EPIX) Stock Passes Below Fifty Day Moving Average of $7.91 - Defense World

Defense World

2500 Shares in Biomea Fusion, Inc. (NASDAQ:BMEA) Acquired by Signaturefd LLC - Defense World

Defense World

Hedge funds investors in ESSA Pharma Inc. (NASDAQ:EPIX) lost 12% last week but have reaped the benefits of longer-term growth - Simply Wall St

Simply Wall St

PBYI Stock Quote Price and Forecast - CNN

CNN

ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business - Yahoo Finance

Yahoo Finance

Exclusive: Norway's wealth fund pushes for more women on emerging market company boards - Reuters.com

Reuters.com

ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results - Yahoo Finance

Yahoo Finance

ESSA Pharma: Fiscal Q1 Earnings Snapshot - Quartz

Quartz

ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares - Yahoo Finance

Yahoo Finance

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday

Benzinga

Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday - Markets Insider

Markets Insider

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term ... - Yahoo Finance

Yahoo Finance

Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session

Benzinga

Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session By Benzinga - Investing.com UK

Investing.com UK

EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024… - Yahoo Finance

Yahoo Finance

Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC ... - PR Newswire

PR Newswire

ESSA Pharma Inc (EPIX) Reports Fiscal Q4 and Full-Year Earnings, Advances in Prostate Cancer ... - Yahoo Finance

Yahoo Finance

EPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat… - Yahoo Finance

Yahoo Finance

EPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23… - Yahoo Finance

Yahoo Finance

EPIX: Moving Towards Phase 2 Trial of EPI-7386 in Combination with Enzalutamide… - Yahoo Finance

Yahoo Finance

EPIX: Deep and Sustained PSA Responses in Phase 1/2 Combination Trial of EPI-7386 and Enzalutamide… - Yahoo Finance

Yahoo Finance

DelveInsight Evaluates a Robust Prostate Cancer Pipeline as 170+ Influential Pharma Players to Set Foot in the Domain - PR Newswire

PR Newswire

Cotações de Ações Americanas: Bolsas ao vivo e últimas notícias - Money Times

Money Times

Essa Pharma discloses new androgen receptor antagonists - BioWorld Online

BioWorld Online

EPIX: Promising Early Data for EPI-7386 in Combination with Enzalutamide… - Yahoo Finance

Yahoo Finance

Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues - BioSpace

BioSpace

StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

Franklin M Berger Net Worth (2024) - GuruFocus.com

GuruFocus.com

Centessa still finding itself as it cuts another program - The Pharma Letter

The Pharma Letter

EPIX: Multiple Ongoing Studies of EPI-7386… - Yahoo Finance

Yahoo Finance

BioSpace Movers & Shakers: National Cancer Institute, Evelo, Eagle, ROME & More - BioSpace

BioSpace

Evelo Biosciences Appoints Marella Thorell as Chief Financial Officer - citybiz

citybiz

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswire

GlobeNewswire

EPIX: Clinical Update on Phase 1 Monotherapy Trial of EPI-7386 Expected in 2Q22… - Yahoo Finance

Yahoo Finance

EPIX: First Patient Dosed in Combination Trial of EPI-7386 and Enzalutamide… - Yahoo Finance

Yahoo Finance

ESSA Pharma Stock: Why I Remain Bullish (NASDAQ:EPIX) - Seeking Alpha

Seeking Alpha

Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration - PR Newswire

PR Newswire

Novel NTD Inhibitor EPI-7386 Plus Enzalutamide Under Evaluation in mCRPC - OncLive

OncLive

Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies - GlobeNewswire

GlobeNewswire

Medicxi launches asset-centric Centessa by acquiring 10 companies - BioWorld Online

BioWorld Online